Hims & Hers is now offering discounted access to Wegovy, a GLP-1 manufactured by Novo Nordisk, on its platform. The post Novo Nordisk Forms GLP-1 Partnership with Hims & Hers appeared first on MedCity News.
During a recent panel, hospital leaders discussed how they approach the balancing act between innovation and financial sustainability. They shared tactics such as reassessing vendor contracts, leaning into existing tech capabilities and finding creative ways to support patients without compromising margins. The post Hospitals Leaders Share How They’re Balancing Finance, Innovation and Patient Care appeared…
It seems like the answer is now ‘yes’. EndPoints reports: Stealth BioTherapeutics said the FDA would not meet its Tuesday deadline for approving or rejecting the company’s drug, elamipretide. It had been seeking regulatory clearance of elamipretide for a rare disease called Barth syndrome, which affects only about 150 people in the US and causes…
Abeona Therapeutics makes Zevaskyn by engineering a patient’s biopsied skin cells to express the collagen that they lack, then growing those cells into sheets that can be surgically applied to a wound. Abeona’s cell-based gene therapy is just the third FDA-approved treatment for epidermolysis bullosa, a rare disease that leads to skin described as thin…
This brief considers how default enrollment into Medicare Advantage might work, potential challenges with this approach, and implications for beneficiaries, insurers, providers, agents and brokers, and the federal budget.
AIQ is not just about adopting a new technology. We’re talking about a fundamentally different way of thinking. A shift in what’s possible in clinical research, and a new standard for execution. The post The AIQ Imperative: A New Competitive Paradigm for BioPharma appeared first on MedCity News.
For employers to offer effective, accessible and affordable value-based care for their employees, they must address these four components. The post How Employers Can Leverage Value-Based Care to Drive Retention and Improved Health Outcomes for Employees appeared first on MedCity News.
[Sponsored] Sign up today and and join us on May 8th where we’ll explore how a banking platform approach could be a resource for the needs of entrepreneurs across biotech, diagnostics, and other life science companies. The post Webinar: How Fintech Can Accelerate Growth for Early-Stage Life Science Companies appeared first on MedCity News.
By JEFF GOLDSMITH A Forty Year Growth Saga is Coming to an End After market close Wednesday April 16, UnitedHealth Group reported its First Quarter 2025 earnings. UNH missed their expected 1Q earnings by 9 cents a share, but the firm also lowered its full year 2025 earnings estimate by 12%. On Thursday opening, investors…
Adelaide Tovar, a University of Michigan scientist who researches genes related to diabetes, used to feel like an impostor in a laboratory. Tovar, 32, grew up poor and was the first in her family to graduate from high school. During her first year in college, she realized she didn’t know how to study. But after…